Insider · CIK 0001601360

Gilbert Halley E

Reports to the SEC for 7 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001601360

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+59K sh	—	—	59,000
2026-06-15	PCVXVaxcyte, Inc.A Award	Director	AAward	+2,265 sh	—	—	12,481
2026-06-15	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.4K sh	—	—	11,389
2026-06-05	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+5,778 sh	—	—	27,901
2026-06-05	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.7K sh	—	—	16,667
2025-11-20	ARQTArcutis Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+12.2K sh	$7.51	+$91.8K	38,655
2025-11-20	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−16.5K sh	$27.55	−$455K	22,123
2025-11-20	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−12.2K sh	—	—	0
2025-06-12	PCVXVaxcyte, Inc.A Award	Director	AAward	+3,041 sh	—	—	10,216
2025-06-12	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.4K sh	—	—	15,372
2025-06-12	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+7,609 sh	—	—	26,435
2025-06-12	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20.6K sh	—	—	20,568
2025-06-11	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+38K sh	—	—	38,000
2024-06-14	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+10.1K sh	—	—	18,826
2024-06-14	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+27.1K sh	—	—	27,052
2024-06-06	PCVXVaxcyte, Inc.A Award	Director	AAward	+1,550 sh	—	—	7,175
2024-06-06	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,250 sh	—	—	7,250
2024-06-03	PCVXVaxcyte, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+18.2K sh	$5.35	+$97.4K	23,825
2024-06-03	PCVXVaxcyte, Inc.S Sale	Director	SSale	−18.2K sh	$73.00	−$1.33M	5,625
2024-06-03	PCVXVaxcyte, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−18.2K sh	—	—	30,374
2024-05-15	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+38K sh	—	—	38,000
2023-06-14	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-06-13	PCVXVaxcyte, Inc.A Award	Director	AAward	+2,500 sh	—	—	5,625
2023-06-13	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2023-05-31	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+4,375 sh	—	—	8,687
2023-05-31	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.2K sh	—	—	12,220
2022-06-15	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-06-01	PCVXVaxcyte, Inc.A Award	Director	AAward	+3,125 sh	—	—	3,125
2022-06-01	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	Director	AAward	+18.8K sh	—	—	18,750
2022-06-01	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+4,312 sh	—	—	4,312
2022-06-01	ARQTArcutis Biotherapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.8K sh	—	—	11,796
2022-03-01	NEONEOGENOMICS INCA Award	Chief Legal Officer	AAward	+42K sh	—	—	147,396
2022-03-01	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+103K sh	—	—	102,623
2021-12-31	NEONEOGENOMICS INCL Small Acquisition	Chief Legal Officer	LSmall Acquisition	+177 sh	$31.30	+$5,540.1	105,263
2021-12-30	NEONEOGENOMICS INCA Award	Chief Legal Officer	AAward	+45.9K sh	—	—	105,086
2021-08-17	NEONEOGENOMICS INCA Award	Chief Legal Officer	AAward	+59.2K sh	—	—	59,228
2021-08-17	NEONEOGENOMICS INC · Common StockA Award	Chief Legal Officer	AAward	+63.3K sh	—	—	63,331
2021-06-16	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-06-09	ARQTArcutis Biotherapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13.4K sh	—	—	13,391
2021-06-02	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	Director	AAward	−15K sh	—	—	15,000
2020-06-17	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-05-01	ARQTArcutis Biotherapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+37.5K sh	—	—	37,500
2020-04-27	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2020-02-21	IRWDIRONWOOD PHARMACEUTICALS INCS Sale	Chief Admin Officer & SVP	SSale	−2,753 sh	$11.63	−$32K	278,566
2020-02-21	IRWDIRONWOOD PHARMACEUTICALS INCS Sale	Chief Admin Officer & SVP	SSale	−3,410 sh	$11.63	−$39.7K	275,156
2020-02-21	IRWDIRONWOOD PHARMACEUTICALS INCS Sale	Chief Admin Officer & SVP	SSale	−2,984 sh	$11.63	−$34.7K	272,172
2020-02-21	IRWDIRONWOOD PHARMACEUTICALS INCS Sale	Chief Admin Officer & SVP	SSale	−6,181 sh	$11.63	−$71.9K	265,991
2020-02-20	Dermira, Inc.Director Stock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2020-01-31	IRWDIRONWOOD PHARMACEUTICALS INCM Exercise/Conversion	Chief Admin Officer & SVP	MExercise/Conversion	+60K sh	$10.02	+$601K	341,319
2020-01-31	IRWDIRONWOOD PHARMACEUTICALS INCS Sale	Chief Admin Officer & SVP	SSale	−60K sh	$12.05	−$723K	281,319

Recent filings

Accepted (ET)
Jun 224
Gilbert Halley E0001610717-26-000276
SEC(opens sec.gov)
Jun 164
Gilbert Halley E0001601360-26-000002
SEC(opens sec.gov)
Jun 94
Gilbert Halley E0001628280-26-042040
SEC(opens sec.gov)
Nov 214
Gilbert Halley E0001601360-25-000007
SEC(opens sec.gov)
Jun 164
Gilbert Halley E0001601360-25-000003
SEC(opens sec.gov)
Jun 164
Gilbert Halley E0002065881-25-000023
SEC(opens sec.gov)
Jun 134
Gilbert Halley E0001610717-25-000210
SEC(opens sec.gov)
Jun 184
Gilbert Halley E0001787306-24-000100
SEC(opens sec.gov)
Jun 104
Gilbert Halley E0001649094-24-000013
SEC(opens sec.gov)
Jun 54
Gilbert Halley E0001415889-24-015590
SEC(opens sec.gov)

Companies

Address

C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD., STE. 400

SOUTH SAN FRANCISCO, CA, 94080